• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肝脏成像在遗传性出血性毛细血管扩张症中的作用

The Role of Liver Imaging in Hereditary Hemorrhagic Telangiectasia.

作者信息

Harwin Joelle, Sugi Mark D, Hetts Steven W, Conrad Miles B, Ohliger Michael A

机构信息

Department of Radiology and Biomedical Imaging, University of California, San Francisco, CA 94143, USA.

Department of Radiology, Zuckerberg San Francisco General Hospital, San Francisco, CA 94110, USA.

出版信息

J Clin Med. 2020 Nov 21;9(11):3750. doi: 10.3390/jcm9113750.

DOI:10.3390/jcm9113750
PMID:33233377
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7700186/
Abstract

Hereditary hemorrhagic telangiectasia (HHT) is an autosomal dominant vascular disorder characterized by spontaneous epistaxis, telangiectasia, and visceral vascular malformations. Hepatic vascular malformations are common, though a minority are symptomatic. Symptoms are dependent on the severity and exact type of shunting caused by the hepatic malformation: Arteriosystemic shunting leads to manifestations of high output cardiac failure, and arterioportal shunting leads to portal hypertension. Radiologic imaging, including ultrasound, computed tomography (CT), and magnetic resonance imaging (MRI), is an important tool for assessing liver involvement. Doppler ultrasonography is the first-line screening modality for HHT-related liver disease, and it has a standardized scale. Imaging can determine whether shunting is principally to the hepatic vein or the portal vein, which can be a key determinant of patients' symptoms. Liver-related complications can be detected, including manifestations of portal hypertension, focal liver masses as well as ischemic cholangiopathy. Ultrasound and MRI also have the ability to quantify blood flow through the liver, which in the future may be used to determine prognosis and direct antiangiogenic therapy.

摘要

遗传性出血性毛细血管扩张症(HHT)是一种常染色体显性血管疾病,其特征为自发性鼻出血、毛细血管扩张和内脏血管畸形。肝血管畸形很常见,不过少数有症状。症状取决于肝畸形导致的分流的严重程度和确切类型:动-体循环分流导致高输出量心力衰竭的表现,而动-门脉分流导致门静脉高压。包括超声、计算机断层扫描(CT)和磁共振成像(MRI)在内的放射学成像,是评估肝脏受累情况的重要工具。多普勒超声检查是HHT相关肝脏疾病的一线筛查方式,且有标准化的量表。成像可确定分流主要是进入肝静脉还是门静脉,这可能是患者症状的关键决定因素。可检测出与肝脏相关的并发症,包括门静脉高压的表现、肝脏局灶性肿块以及缺血性胆管病。超声和MRI还能够量化通过肝脏的血流量,未来这可能用于确定预后及指导抗血管生成治疗。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/871c/7700186/25d780f66909/jcm-09-03750-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/871c/7700186/736e90e2b81b/jcm-09-03750-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/871c/7700186/59e9a9ce9759/jcm-09-03750-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/871c/7700186/fba4189529d0/jcm-09-03750-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/871c/7700186/5c03cff90cf1/jcm-09-03750-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/871c/7700186/67942b266f0f/jcm-09-03750-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/871c/7700186/476885f10d3c/jcm-09-03750-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/871c/7700186/93a9bc63da86/jcm-09-03750-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/871c/7700186/65707159af39/jcm-09-03750-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/871c/7700186/ec0421d2e6e3/jcm-09-03750-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/871c/7700186/25d780f66909/jcm-09-03750-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/871c/7700186/736e90e2b81b/jcm-09-03750-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/871c/7700186/59e9a9ce9759/jcm-09-03750-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/871c/7700186/fba4189529d0/jcm-09-03750-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/871c/7700186/5c03cff90cf1/jcm-09-03750-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/871c/7700186/67942b266f0f/jcm-09-03750-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/871c/7700186/476885f10d3c/jcm-09-03750-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/871c/7700186/93a9bc63da86/jcm-09-03750-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/871c/7700186/65707159af39/jcm-09-03750-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/871c/7700186/ec0421d2e6e3/jcm-09-03750-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/871c/7700186/25d780f66909/jcm-09-03750-g010.jpg

相似文献

1
The Role of Liver Imaging in Hereditary Hemorrhagic Telangiectasia.肝脏成像在遗传性出血性毛细血管扩张症中的作用
J Clin Med. 2020 Nov 21;9(11):3750. doi: 10.3390/jcm9113750.
2
Congestive cirrhosis in Osler-Weber-Rendu syndrome: A rare case report.奥-韦-伦综合征中的充血性肝硬化:一例罕见病例报告。
Radiol Case Rep. 2017 Nov 6;13(1):51-54. doi: 10.1016/j.radcr.2017.10.011. eCollection 2018 Feb.
3
Hepatic sonography in patients with hereditary hemorrhagic telangiectasia hospitalized for epistaxis.因鼻出血住院的遗传性出血性毛细血管扩张症患者的肝脏超声检查
J Ultrasound. 2012 Sep;15(3):164-70. doi: 10.1016/j.jus.2012.04.001. Epub 2012 Apr 20.
4
Pulmonary vascular manifestations of hereditary hemorrhagic telangiectasia (rendu-osler disease).遗传性出血性毛细血管扩张症(伦杜-奥斯勒病)的肺血管表现
Respiration. 2007;74(4):361-78. doi: 10.1159/000103205.
5
Liver involvement in hereditary hemorrhagic telangiectasia (HHT).遗传性出血性毛细血管扩张症(HHT)中的肝脏受累情况。
J Hepatol. 2007 Mar;46(3):499-507. doi: 10.1016/j.jhep.2006.12.008. Epub 2007 Jan 2.
6
[Liver involvement in hereditary hemorrhagic telangiectasia].[遗传性出血性毛细血管扩张症中的肝脏受累]
Acta Gastroenterol Latinoam. 2011 Sep;41(3):225-9.
7
Liver Findings in Patients with Hereditary Hemorrhagic Telangiectasia.遗传性出血性毛细血管扩张症患者的肝脏表现
Iran J Radiol. 2016 Jun 22;13(4):e31116. doi: 10.5812/iranjradiol.31116. eCollection 2016 Oct.
8
Hereditary hemorrhagic telangiectasia.遗传性出血性毛细血管扩张症
Handb Clin Neurol. 2015;132:185-97. doi: 10.1016/B978-0-444-62702-5.00013-5.
9
Osler-Weber-Rendu disease presenting with hepatocellular carcinoma: radiologic and genetic findings.以肝细胞癌为表现的遗传性出血性毛细血管扩张症:影像学和遗传学发现
Korean J Hepatol. 2011 Dec;17(4):313-8. doi: 10.3350/kjhep.2011.17.4.313.
10
Imaging of hereditary hemorrhagic telangiectasia.遗传性出血性毛细血管扩张症的影像学检查
Cardiovasc Intervent Radiol. 2009 Jul;32(4):745-57. doi: 10.1007/s00270-008-9344-2. Epub 2008 Oct 30.

引用本文的文献

1
Imaging manifestations of hereditary hemorrhagic telangiectasia with pulmonary arterial hypertension: a case report.遗传性出血性毛细血管扩张症合并肺动脉高压的影像学表现:一例报告
Front Cardiovasc Med. 2025 Mar 21;12:1548130. doi: 10.3389/fcvm.2025.1548130. eCollection 2025.
2
A Rare Association: Hereditary Hemorrhagic Telangiectasia with Liver Cirrhosis Causing Portal Hypertension.一种罕见的关联:遗传性出血性毛细血管扩张症与导致门静脉高压的肝硬化。
Case Rep Gastrointest Med. 2024 Jan 17;2024:3574725. doi: 10.1155/2024/3574725. eCollection 2024.
3
Right hemihepatectomy combined with ligation of the common hepatic artery and gastroduodenal artery for the treatment of intrahepatic HHT: A case report.

本文引用的文献

1
Second International Guidelines for the Diagnosis and Management of Hereditary Hemorrhagic Telangiectasia.遗传性出血性毛细血管扩张症诊断与管理的第二版国际指南。
Ann Intern Med. 2020 Dec 15;173(12):989-1001. doi: 10.7326/M20-1443. Epub 2020 Sep 8.
2
Monitoring Arteriovenous Malformation Response to Genotype-Targeted Therapy.监测动静脉畸形对基因靶向治疗的反应。
Pediatrics. 2020 Sep;146(3). doi: 10.1542/peds.2019-3206.
3
Liver cirrhosis in a patient with hepatic hereditary hemorrhagic telangiectasia and Budd-Chiari syndrome: a case report.
右半肝切除术联合肝总动脉及胃十二指肠动脉结扎术治疗肝内遗传性出血性毛细血管扩张症:1例报告
Front Surg. 2022 Aug 9;9:900297. doi: 10.3389/fsurg.2022.900297. eCollection 2022.
肝遗传性出血性毛细血管扩张症合并布加综合征患者的肝硬化:一例报告
BMC Gastroenterol. 2020 Jun 3;20(1):169. doi: 10.1186/s12876-020-01311-1.
4
Hereditary hemorrhagic telangiectasia: how to efficiently detect hepatic abnormalities using ultrasonography.遗传性出血性毛细血管扩张症:如何利用超声检查有效检测肝脏异常。
J Med Ultrason (2001). 2020 Jul;47(3):421-433. doi: 10.1007/s10396-020-01022-w. Epub 2020 May 10.
5
The role of contrast-enhanced ultrasound in neurosurgical disease.超声造影在神经外科疾病中的应用
Neurosurg Focus. 2019 Dec 1;47(6):E8. doi: 10.3171/2019.9.FOCUS19624.
6
Identification of two distinct hereditary hemorrhagic telangiectasia patient subsets with different hepatic perfusion properties by combination of contrast-enhanced ultrasound (CEUS) with perfusion imaging quantification.通过对比增强超声(CEUS)与灌注成像定量相结合,鉴定两种具有不同肝灌注特性的遗传性出血性毛细血管扩张症患者亚组。
PLoS One. 2019 Apr 11;14(4):e0215178. doi: 10.1371/journal.pone.0215178. eCollection 2019.
7
Abdominal manifestations of hereditary hemorrhagic telangiectasia: a series of 333 patients over 15 years.遗传性出血性毛细血管扩张症的腹部表现:15 年以上 333 例患者系列。
Abdom Radiol (NY). 2019 Jul;44(7):2384-2391. doi: 10.1007/s00261-019-01976-7.
8
Safety of thalidomide and bevacizumab in patients with hereditary hemorrhagic telangiectasia.遗传性出血性毛细血管扩张症患者使用沙利度胺和贝伐珠单抗的安全性。
Orphanet J Rare Dis. 2019 Feb 4;14(1):28. doi: 10.1186/s13023-018-0982-4.
9
Pazopanib may reduce bleeding in hereditary hemorrhagic telangiectasia.帕唑帕尼可能减少遗传性出血性毛细血管扩张症的出血。
Angiogenesis. 2019 Feb;22(1):145-155. doi: 10.1007/s10456-018-9646-1. Epub 2018 Sep 6.
10
Liver involvement in hereditary hemorrhagic telangiectasia.遗传性出血性毛细血管扩张症的肝脏受累。
Abdom Radiol (NY). 2018 Aug;43(8):1920-1930. doi: 10.1007/s00261-018-1671-4.